Contact a LawyerSubmit information about your potential case to be reviewed by an attorney.
Published: December 28th, 2011
Side effects of NuvaRing birth control has been associated with a number of serious and potentially fatal injuries caused by blood clots. Users have suffered pulmonary embolysms, deep vein thrombosis, heart attacks, strokes and death after using the contraceptive vaginal ring.
STATUS OF NUVARING LITIGATION: All federal NuvaRing lawsuits filed in federal court by individuals who allege injuries as a result of the birth control ring have been consolidated in the Eastern District of Missouri as part of an MDL, or multidistrict litigation. Additional cases have been filed in New Jersey state court, as well as other state court systems.
NuvaRing lawyers are continuing to review new cases for users who have suffered:
- Blood Clots
- Pulmonary Embolysm
- Deep Vein Thrombosis (DVT)
- Heart Attack
MANUFACTURERS: Merck subsidiaries Organon Pharmaceuticals USA Inc., Organon USA Inc., Organon International Inc., Schering Plough Corp., and Akzo Nobel NV.
OVERVIEW: The NuvaRing is a once-a-month combined contraceptive vaginal ring, which was approved for use in the United States in October 2001. It is a birth control ring that is inserted in the vagina and used to prevent unwanted pregnancies.
Nuva Ring works by releasing controlled amounts of ethinyl estradiol (EE) and etonogestrel, which combine to modify female hormones.
NUVARING BLOOD CLOT SIDE EFFECTS: The use of NuvaRing birth control has been associated with an increased risk of blood clots, which could lead to serious and potentially fatal injuries.
Blood clots, also known as thrombosis, can occur when blood cells clump together in the vein, restricting blood flow. If the blood clot forms in the deep veins of the legs, pelvis or arms, known as deep vein thrombosis, this could severely restrict blood flow to the heart, lungs or brain.
If a blood clot breaks off and travels through the blood stream, it could get lodged near the lung causing a pulmonary embolism. The pulmonary artery is the main intake valve of blood into the lungs, and if this artery is blocked, the body could suffer from a lack of oxygen.
The use of the NuvaRing has been found to potentially increase the risk of blood clots, deep vein thrombosis and pulmonary embolism, which could also lead to an ischemic stroke, heart attack or sudden death.